LEO Pharma establishes company in China

Shanghai, China

- LEO Pharma is establishing a strategic company in China to market drugs for the treatment of psoriasis and other skin diseases, MarketWatch reports.

LEO Pharma China, the new company, will market Daivobet, LEO Pharma's psoriasis brand, which was recently approved by the Chinese authorities in order to market the drug in China.